Is geographic mismatch linked to short-term major heart problems after long drug-eluting stent placement?

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study examines if geographic mismatch independently forecasts short-term major adverse cardiovascular events in patients undergoing long drug-eluting stent implantation during PCI. It builds on known risk factors for adverse outcomes after PCI and seeks to isolate the potential impact of geographic mismatch on post-procedure events. The analysis will involve patients who receive a DES of at least 38 mm and will exclude those with bare-metal stents, cardiogenic shock, in-stent restenosis, prior stents in the target segment, or limited follow-up. Data collection covers clinical, angiographic, and procedural variables to determine any independent association with short-term outcomes. The setting is Sohag University, focusing on patients treated at that institution.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥18 years old.
* Both sexes.
* Patients undergo percutaneous coronary intervention (PCI) with successful implantation of a drug-eluting stent (DES) measuring ≥38 mm in length.
* Successful stent deployment with discharge after PCI.

Exclusion Criteria:

* Bare-metal stent (BMS) implantation.
* Cardiogenic shock at presentation.
* In-stent restenosis lesions.
* Previous stent implantation in the target coronary segment.
* Life expectancy \<6 months due to non-cardiac causes.
* Incomplete clinical or geographic data.
* Patients lost to follow-up immediately after hospital discharge.

Where it's running

• Sohag University
  Sohag, Egypt Recruiting

Study contacts

• Study coordinator: Remon S Adly, MD
• Email: remonsaleh@yahoo.com
• Phone: 00201221878986

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Plasma multi-omics prediction of left ventricular remodeling and major cardiac events after STEMI

  This research tests whether blood multi-omics (proteins, metabolites, lipids, transcripts and immune markers) can predict left ventricular adverse remodeling (LVAR) and major adverse cardiovascular events (MACE) in adults after a first STEMI treated with primary PCI.

  Recruiting Beijing Anzhen Hospital · Beijing, Beijing Municipality · NCT06885619

• Assessing the Systolic Rise Time's ability to predict limb and cardiovascular events in severe peripheral artery disease

  This study is testing if a specific measurement from the foot can help predict serious problems with limbs and heart health in people with severe peripheral artery disease.

  Recruiting Centre Hospitalier Universitaire, Amiens · Amiens · NCT06318767

• Using CCTA to improve management of stable chest pain

  This study is testing if using a special heart scan called CCTA can help doctors better manage stable chest pain and reduce serious heart problems for patients suspected of having blocked arteries.

  Recruiting at 4 sites Tianjin Chest Hospital · Beijing, Beijing Municipality and 3 other locations · NCT04691037

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.